At leon-nanodrugs, I work with FR-JET technology to formulate LNPs and other nanoparticles, then characterize the formulations using DLS. My work connects nanoparticle formulation with RNA therapeutics.
At LMU Klinikum München, I developed a broad-spectrum antiviral approach using redundant siRNA pools against coronaviruses. I designed siRNAs, analyzed mismatches against viral targets, and studied viral escape in HCoV-OC43.

